147 related articles for article (PubMed ID: 38472526)
1. Radiological biomarkers reflecting visceral fat distribution help distinguish inflammatory bowel disease subtypes: a multicenter cross-sectional study.
Xiong Z; Wu P; Zhang Y; Chen J; Shen Y; Kamel I; Wu B; Zheng X; Li Z
Insights Imaging; 2024 Mar; 15(1):70. PubMed ID: 38472526
[TBL] [Abstract][Full Text] [Related]
2. Visceral adiposity and inflammatory bowel disease.
Rowan CR; McManus J; Boland K; O'Toole A
Int J Colorectal Dis; 2021 Nov; 36(11):2305-2319. PubMed ID: 34104989
[TBL] [Abstract][Full Text] [Related]
3. Volumetric visceral fat machine learning phenotype on CT for differential diagnosis of inflammatory bowel disease.
Zhou Z; Xiong Z; Cheng R; Luo Q; Li Y; Xie Q; Xiao P; Hu D; Hu X; Shen Y; Li Z
Eur Radiol; 2023 Mar; 33(3):1862-1872. PubMed ID: 36255487
[TBL] [Abstract][Full Text] [Related]
4. Differentiation Between Ulcerative Colitis and Crohn's Disease Using Abdominal Computed Tomography in Patients With First-Time Inflammatory Bowel Disease.
Yamamoto S; Yoshida N; Sakurai N; Ichikawa A; Takeshita K; Okada Y
Cureus; 2024 May; 16(5):e59691. PubMed ID: 38840987
[TBL] [Abstract][Full Text] [Related]
5. CT-based radiomics signature of visceral adipose tissue for prediction of disease progression in patients with Crohn's disease: A multicentre cohort study.
Li X; Zhang N; Hu C; Lin Y; Li J; Li Z; Cui E; Shi L; Zhuang X; Li J; Lu J; Wang Y; Liu R; Yuan C; Lin H; He J; Ke D; Tang S; Zou Y; He B; Sun C; Chen M; Huang B; Mao R; Feng ST
EClinicalMedicine; 2023 Feb; 56():101805. PubMed ID: 36618894
[TBL] [Abstract][Full Text] [Related]
6. Visceral Adiposity Independently Predicts Time to Flare in Inflammatory Bowel Disease but Body Mass Index Does Not.
Sehgal P; Su S; Zech J; Nobel Y; Luk L; Economou I; Shen B; Lewis JD; Freedberg DE
Inflamm Bowel Dis; 2024 Apr; 30(4):594-601. PubMed ID: 37307420
[TBL] [Abstract][Full Text] [Related]
7. Impact of abdominal visceral adipose tissue on disease outcome in pediatric Crohn's disease.
Uko V; Vortia E; Achkar JP; Karakas P; Fiocchi C; Worley S; Kay MH
Inflamm Bowel Dis; 2014 Dec; 20(12):2286-91. PubMed ID: 25222655
[TBL] [Abstract][Full Text] [Related]
8. Differential expression of serum miR-486 and miR-25 in ulcerative colitis and Crohn's disease: Correlations with disease activity, extent, and location.
Abdelazim SA; Shaker OG; Ali O; El-Tawil M; Senousy MA
Pathol Res Pract; 2023 Dec; 252():154910. PubMed ID: 37939427
[TBL] [Abstract][Full Text] [Related]
9. Association between body fat composition and disease duration, clinical activity, and intravenous corticosteroid-induced response in inflammatory bowel disease.
He S; Huang Y; Peng Y; Chai J; Chen K
Lipids Health Dis; 2023 Jul; 22(1):106. PubMed ID: 37481662
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of bacterial biomarkers to aid in challenging inflammatory bowel diseases diagnostics and subtype classification.
Lopez-Siles M; Aldeguer X; Sabat-Mir M; Serra-Pagès M; Duncan SH; Flint HJ; Garcia-Gil LJ; Martinez-Medina M
World J Gastrointest Pathophysiol; 2020 May; 11(3):64-77. PubMed ID: 32435523
[TBL] [Abstract][Full Text] [Related]
11. Computed tomography-based body composition parameters can predict short-term prognosis in ulcerative colitis patients.
Lu J; Xu H; Shi H; Zheng J; Cheng T; Zhou M; Han X; Wang Y; Meng X; Li X; Jiang J; Li P; Yang Z; Xu L
Insights Imaging; 2024 Feb; 15(1):60. PubMed ID: 38411849
[TBL] [Abstract][Full Text] [Related]
12. Fungal and Bacterial Loads: Noninvasive Inflammatory Bowel Disease Biomarkers for the Clinical Setting.
Sarrabayrouse G; Elias A; Yáñez F; Mayorga L; Varela E; Bartoli C; Casellas F; Borruel N; Herrera de Guise C; Machiels K; Vermeire S; Manichanh C
mSystems; 2021 Mar; 6(2):. PubMed ID: 33758031
[TBL] [Abstract][Full Text] [Related]
13. Ulcerative colitis, Crohn's disease, and irritable bowel syndrome have different profiles of extracellular matrix turnover, which also reflects disease activity in Crohn's disease.
Mortensen JH; Manon-Jensen T; Jensen MD; Hägglund P; Klinge LG; Kjeldsen J; Krag A; Karsdal MA; Bay-Jensen AC
PLoS One; 2017; 12(10):e0185855. PubMed ID: 29028807
[TBL] [Abstract][Full Text] [Related]
14. Integrated analysis of multiple microarray studies to establish differential diagnostic models of Crohn's disease and ulcerative colitis based on a metalloproteinase-associated module.
Deng J; Zhao N; Lv LP; Ma P; Zhang YY; Xu JB; Zhou XP; Chen ZA; Zhang YY
Front Immunol; 2022; 13():1022850. PubMed ID: 36479126
[TBL] [Abstract][Full Text] [Related]
15. Development and Validation of Diagnostic Criteria for IBD Subtypes Including IBD-unclassified in Children: a Multicentre Study From the Pediatric IBD Porto Group of ESPGHAN.
Birimberg-Schwartz L; Zucker DM; Akriv A; Cucchiara S; Cameron FL; Wilson DC; Lazowska I; Yianni L; Paul SP; Romano C; Kolacek S; Buderus S; Pærregaard A; Russell RK; Escher JC; Turner D;
J Crohns Colitis; 2017 Sep; 11(9):1078-1084. PubMed ID: 28430891
[TBL] [Abstract][Full Text] [Related]
16. Visceral Adipose Tissue Volumetrics Inform Odds of Treatment Response and Risk of Subsequent Surgery in IBD Patients Starting Antitumor Necrosis Factor Therapy.
Gu P; Chhabra A; Chittajallu P; Chang C; Mendez D; Gilman A; Fudman DI; Xi Y; Feagins LA
Inflamm Bowel Dis; 2022 May; 28(5):657-666. PubMed ID: 34291800
[TBL] [Abstract][Full Text] [Related]
17. PR3-ANCA and panel diagnostics in pediatric inflammatory bowel disease to distinguish ulcerative colitis from Crohn's disease.
Horn MP; Peter AM; Righini Grunder F; Leichtle AB; Spalinger J; Schibli S; Sokollik C
PLoS One; 2018; 13(12):e0208974. PubMed ID: 30557305
[TBL] [Abstract][Full Text] [Related]
18. Morphologic criteria applicable to biopsy specimens for effective distinction of inflammatory bowel disease from other forms of colitis and of Crohn's disease from ulcerative colitis.
Tanaka M; Riddell RH; Saito H; Soma Y; Hidaka H; Kudo H
Scand J Gastroenterol; 1999 Jan; 34(1):55-67. PubMed ID: 10048734
[TBL] [Abstract][Full Text] [Related]
19. Fragments of Citrullinated and MMP-degraded Vimentin and MMP-degraded Type III Collagen Are Novel Serological Biomarkers to Differentiate Crohn's Disease from Ulcerative Colitis.
Mortensen JH; Godskesen LE; Jensen MD; Van Haaften WT; Klinge LG; Olinga P; Dijkstra G; Kjeldsen J; Karsdal MA; Bay-Jensen AC; Krag A
J Crohns Colitis; 2015 Oct; 9(10):863-72. PubMed ID: 26188349
[TBL] [Abstract][Full Text] [Related]
20. Cancer Risk in Inflammatory Bowel Disease: A 6-Year Prospective Multicenter Nested Case-Control IG-IBD Study.
Biancone L; Armuzzi A; Scribano ML; Castiglione F; D'Incà R; Orlando A; Papi C; Daperno M; Vecchi M; Riegler G; Fries W; Alvisi P; Meucci G; Mocciaro F; Rogai F; Festa S; Guidi L; Testa A; Spina L; Renna S; Viola A; Patturelli M; Di Mitri R; Frankovic I; Calabrese E; Petruzziello C; De Cristofaro E; Sena G; Ruffa A; Neri B; Rossi A
Inflamm Bowel Dis; 2020 Feb; 26(3):450-459. PubMed ID: 31498388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
